Levofloxacin Export Market Intelligence: India's 699 Suppliers Shipping to 150 Countries — TransData Nexus 2026

Q: Who are the top levofloxacin exporters from India?

The top levofloxacin exporters from India are: 1. MACLEODS PHARMACEUTICALS LTD — $9.5M (13.2% market share); 2. MICRO LABS LIMITED — $5.0M (7.0% market share); 3. SENTISS PHARMA PRIVATE LIMITED — $4.7M (6.5% market share); 4. ZYPHER LIFESCIENCES PRIVATE LIMITED — $3.7M (5.2% market share); 5. MEDCELL PHARMA — $3.7M (5.1% market share). Together they account for 37.0% of India's total levofloxacin export value.

Q: What is the total export value of levofloxacin from India?

The total export value of levofloxacin from India is $72.1M USD, recorded across 6,304 shipment transactions from 699 active exporters to 150 destination countries. The average shipment value is $11.4K.

Q: Which countries import levofloxacin from India?

India exports levofloxacin to 150 countries worldwide. The top importing countries are: RUSSIA (8.1% share, $5.8M), UZBEKISTAN (8.0% share, $5.8M), UNITED STATES (7.7% share, $5.6M), TURKEY (6.5% share, $4.7M), IRAQ (6.4% share, $4.6M). These five markets account for 36.8% of total export value.

Q: What is the HS code for levofloxacin exports from India?

The primary HS code for levofloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of levofloxacin exports from India?

The average unit price for levofloxacin exports from India is $7.38 USD per unit, with prices ranging from $0.00 to $1725.99 depending on formulation, packaging, and order volume. The total market is valued at $72.1M across 6,304 shipments.

Q: Which ports handle levofloxacin exports from India?

The primary ports for levofloxacin exports from India are SAHAR AIR (10.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (9.8% of shipments), DELHI AIR (8.4% of shipments), NHAVA SHEVA SEA (INNSA1) (7.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of levofloxacin?

India is one of the world's leading exporters of levofloxacin due to its large base of 699 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports levofloxacin to 150 countries, demonstrating 77% global market coverage.

Q: What certifications do Indian levofloxacin exporters need?

Indian levofloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import levofloxacin from India?

There are 1,543 registered buyers importing levofloxacin from India, spread across 150 countries. The repeat buyer rate is 53.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top levofloxacin supplier from India?

MACLEODS PHARMACEUTICALS LTD is the leading levofloxacin exporter from India with a market share of 13.2% and total export value of $9.5M across 256 shipments. The top 5 suppliers together control 37.0% of total export value.

Suresh Sormare

Levofloxacin

India Pharmaceutical Trade Intelligence

$72.1M699 Suppliers150 CountriesHS 30049099

ExportsIndia → RUSSIA8.1%India → UZBEKISTAN8.0%

ImportsMALTA → India$59.6M ISRAEL → India$1.7M

#1 Buyer: YILMAZ TRANSPORT

Levofloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Levofloxacin to the World

Between 2022 and 2026, India exported $72.1M worth of levofloxacin across 6,304 verified shipments to 150 countries — covering 77% of world markets in the Antibiotics segment. The largest destination is RUSSIA (8.1%). MACLEODS PHARMACEUTICALS LTD leads with a 13.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Levofloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Levofloxacin export data snapshot — $72.1M · 699 exporters · 150 countriesTransData Nexus · Indian Customs Data

Top Levofloxacin Exporters from India

699 active exporters · Ranked by export value

View all 699 →

Top Levofloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MACLEODS PHARMACEUTICALS LTD	$9.5M	256	34	13.2%
2	MICRO LABS LIMITED

Top Countries Importing Levofloxacin from India

150 destination markets · Ranked by import value

All 150 countries →

Top Countries Importing Levofloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	RUSSIA	$5.8M	8.1%
2	UZBEKISTAN	$5.8M	8.0%
3	UNITED STATES	$5.6M	7.7%
4	TURKEY	$4.7M	6.5%
5	IRAQ	$4.6M	6.4%
6	KAZAKHSTAN	$4.0M	5.6%
7	KENYA	$3.0M	4.2%
8	FRANCE	$2.9M	4.1%
9	NIGERIA	$2.6M	3.6%
10	UKRAINE	$2.3M	3.1%

RUSSIA is India's largest levofloxacin export destination, absorbing 8.1% of total exports worth $5.8M. The top 5 importing countries — RUSSIA, UZBEKISTAN, UNITED STATES, TURKEY, IRAQ — together account for 36.8% of India's total levofloxacin export value. The remaining 145 destination countries collectively receive the other 63.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Levofloxacin to India?

21 origin countries · Total import value: $61.4M

India imports levofloxacin from 21 countries with a combined import value of $61.4M. The largest supplier is MALTA ($59.6M, 21 shipments), followed by ISRAEL and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Levofloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	MALTA	$59.6M	21	97.0%
2	ISRAEL	$1.7M	3	2.8%
3	UNITED STATES	$81.8K	22	0.1%
4	JAPAN	$18.3K	4	0.0%
5	BRAZIL	$6.2K	4	0.0%
6	CHINA	$6.1K	2	0.0%
7	GERMANY	$5.9K	2	0.0%
8	UNITED KINGDOM	$2.1K	3	0.0%
9	NETHERLANDS	$1.8K	1	0.0%
10	FINLAND	$1.7K	1	0.0%

Showing top 10 of 21 origin countries

MALTA is the largest supplier of levofloxacin to India, accounting for 97.0% of total import value. The top 5 origin countries — MALTA, ISRAEL, UNITED STATES, JAPAN, BRAZIL — together supply 100.0% of India's levofloxacin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Levofloxacin — Export Intelligence Video

Visual overview of India's levofloxacin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's levofloxacin pharmaceutical import and export market — $72.1M in total trade, 699 verified manufacturers, and 150 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Levofloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, levofloxacin is approved for various indications, including the treatment of bacterial infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for levofloxacin, indicating a competitive generic market. Notably, the original New Drug Application (NDA) for Levaquin (levofloxacin) oral solution was approved on December 21, 2004. Given the presence of 699 active Indian exporters, it is evident that Indian manufacturers play a significant role in supplying levofloxacin to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, levofloxacin is authorized for various indications. The European Medicines Agency (EMA) granted marketing authorization for Quinsair, an inhaled formulation of levofloxacin, on March 25, 2015, for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis. (ema.europa.eu) Additionally, the EMA has conducted periodic safety update reports (PSURs) for levofloxacin, leading to variations in product information to enhance safety profiles. (ema.europa.eu) In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted certain indications for levofloxacin in September 2012, advising its use only when other antibiotics are inappropriate or ineffective. (gov.uk) Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to these regions.

3WHO Essential Medicines & Global Standards

Levofloxacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating bacterial infections. The drug is also subject to WHO Prequalification programs, ensuring its quality, safety, and efficacy for global health procurement. Levofloxacin formulations must comply with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) to meet international quality benchmarks.

4India Regulatory Classification

In India, levofloxacin is classified under Schedule H1 of the Drugs and Cosmetics Rules, 1945, indicating that it is a prescription drug with specific labeling and prescription requirements to prevent misuse. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including levofloxacin, to ensure affordability. Manufacturers exporting levofloxacin are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) as part of the export process.

5Patent & Exclusivity Status

The primary patents for levofloxacin have expired, leading to a robust generic market with multiple manufacturers producing the drug. This generic competition has contributed to the widespread availability and affordability of levofloxacin globally.

6Recent Industry Developments

In July 2024, the EMA published a list of nationally authorized medicinal products containing levofloxacin, reflecting ongoing regulatory oversight. (ema.europa.eu) In December 2025, the EMA issued a Direct Healthcare Professional Communication (DHPC) highlighting the risk of heart valve incompetence associated with systemic and inhaled fluoroquinolones, including levofloxacin. (ema.europa.eu) In October 2025, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information for levofloxacin to include warnings about bone marrow failure, myoclonus, mania, and skin hyperpigmentation. (ema.europa.eu) In June 2023, the FDA approved a 510(k) premarket notification for the VITEK 2 AST-Gram Negative Levofloxacin system, enhancing antimicrobial susceptibility testing capabilities. In September 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of levofloxacin for the treatment of bacterial infections.

These developments underscore the dynamic regulatory landscape surrounding levofloxacin, emphasizing the importance of continuous monitoring and compliance for stakeholders involved in its production and distribution.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Levofloxacin

Retail & reference prices across 9 markets vs. India FOB export price of $7.38/unit

Global Price Benchmark for Levofloxacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.16	USD	According to the FDA Orange Book, Levofloxacin is an approved generic drug, contributing to its affordability in the U.S. market.
United Kingdom	Data not available	GBP	The NHS Drug Tariff provides pricing information for medications; however, specific data for Levofloxacin 500mg tablets is not readily accessible.
Germany	Data not available	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees medication pricing, but specific figures for Levofloxacin 500mg tablets are not publicly disclosed.

Supply Chain Risk Assessment — Levofloxacin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, while robust in manufacturing Active Pharmaceutical Ingredients (APIs) like Levofloxacin, heavily relies on China for Key Starting Materials (KSMs). Approximately 60–70% of KSMs are imported from China, making India vulnerable to supply chain disruptions. This dependency is particularly concerning given that 41% of KSMs used in U.S.-approved APIs are solely sourced from China, as reported by the U.S. Pharmacopeia in October 2025.

Recent geopolitical tensions have exacerbated these vulnerabilities. In February 2026, the closure of the Strait of Hormuz due to military conflicts disrupted the supply of raw materials to Asia's petrochemical industry, affecting the availability of essential chemicals for API production. Such disruptions underscore the risks associated with over-reliance on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

The concentration of Levofloxacin exports among the top five Indian suppliers—holding a combined 37.0% market share—presents a moderate risk. MACLEODS PHARMACEUTICALS LTD leads with a 13.2% share. While this indicates a degree of diversification, the reliance on a limited number of suppliers can pose challenges if any face operational issues.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API production and reduce dependency on imports. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules used in common antibiotics, marking a significant step toward self-reliance.

Access Complete Levofloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 6,304 transactions across 150 markets.

Request Demo View Pricing

Frequently Asked Questions — Levofloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top levofloxacin exporters from India?

The leading levofloxacin exporters from India are MACLEODS PHARMACEUTICALS LTD, MICRO LABS LIMITED, SENTISS PHARMA PRIVATE LIMITED, and 12 others. MACLEODS PHARMACEUTICALS LTD leads with 13.2% market share ($9.5M). The top 5 suppliers together control 37.0% of total export value.

What is the total export value of levofloxacin from India?

The total export value of levofloxacin from India is $72.1M, recorded across 6,304 shipments from 699 active exporters to 150 countries. The average shipment value is $11.4K.

Which countries import levofloxacin from India?

India exports levofloxacin to 150 countries. The top importing countries are RUSSIA (8.1%), UZBEKISTAN (8.0%), UNITED STATES (7.7%), TURKEY (6.5%), IRAQ (6.4%), which together account for 36.8% of total export value.

What is the HS code for levofloxacin exports from India?

The primary HS code for levofloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Levofloxacin

Levofloxacin

Top Levofloxacin Exporters from India

Top Countries Importing Levofloxacin from India

Who Supplies Levofloxacin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Levofloxacin — Export Intelligence Video

Regulatory Landscape — Levofloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Levofloxacin

Supply Chain Risk Assessment — Levofloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Levofloxacin Trade Intelligence

Frequently Asked Questions — Levofloxacin Exports from India

Who are the top levofloxacin exporters from India?

What is the total export value of levofloxacin from India?

Which countries import levofloxacin from India?

What is the HS code for levofloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of levofloxacin exports from India?

Which ports handle levofloxacin exports from India?

Why is India a leading exporter of levofloxacin?

What certifications do Indian levofloxacin exporters need?

How many buyers import levofloxacin from India?

What is the market share of the top levofloxacin exporter from India?

Analysis Methodology